Cargando…
Gut-Brain Endocrine Axes in Weight Regulation and Obesity Pharmacotherapy
In recent years, the obesity epidemic has developed into a major health crisis both in the United States as well as throughout the developed world. With current treatments limited to expensive, high-risk surgery and minimally efficacious pharmacotherapy, new therapeutic options are urgently needed t...
Autores principales: | Merlino, Dante J., Blomain, Erik S., Aing, Amanda S., Waldman, Scott A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449653/ https://www.ncbi.nlm.nih.gov/pubmed/26237477 http://dx.doi.org/10.3390/jcm3030763 |
Ejemplares similares
-
Guanylyl cyclase C signaling axis and colon cancer prevention
por: Pattison, Amanda M, et al.
Publicado: (2016) -
Mechanisms of Weight Regain following Weight Loss
por: Blomain, Erik Scott, et al.
Publicado: (2013) -
Calorie-induced ER stress suppresses uroguanylin satiety signaling in diet-induced obesity
por: Kim, G W, et al.
Publicado: (2016) -
Modulatory Effect of Gut Microbiota on the Gut-Brain, Gut-Bone Axes, and the Impact of Cannabinoids
por: Ibrahim, Iddrisu, et al.
Publicado: (2022) -
GUCY2C at the intersection of obesity and colorectal cancer
por: Waldman, Scott A, et al.
Publicado: (2013)